| CAS ID: | 611168-24-2 |
| Molecular Formula: | C33H38O6 |
| Molecular Weight: | 530.7 g/mol |
| Monoisotopic Mass: | 530.2668 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | HPN-100 | GLYCEROL PHENYLBUTYRATE | RAVICTI |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2 | See All |
| InChI Key: | ZSDBFLMJVAGKOU-UHFFFAOYSA-N | |
| Smiles: | O=C(CCCc1ccccc1)OCC(COC(=O)CCCc2ccccc2)OC(=O)CCCc3ccccc3 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02323100 | Disease | Cystic fibrosis |
| Phase | Phase 1,Phase 2 | Status | Recruiting |
| First Received | December 23, 2014 | Last Verified | December 4, 2018 |
| Sponsor | National Jewish Health | ||
Trial Record 2
| ClinicalTrial ID | NCT00999167 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | October 21, 2009 | Last Verified | January 16, 2017 |
| Sponsor | Horizon Pharma Ireland, Ltd., Dublin Ireland | ||
| PubChem: | 10482134 |
| ChEMBL: | CHEMBL2105745 |